Skip to main content

Advertisement

Log in

Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutic management

  • Letter to the Editor
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kanayama K, Imai H, Usugi E, Shiraishi T, Hirokawa YS, Watanabe M (2018) Association of HER2 gene amplification and tumor progression in early gastric cancer. Virchows Arch 473(5):559–565. https://doi.org/10.1007/s00428-018-2433-y

    Article  PubMed  CAS  Google Scholar 

  2. Yan Y, Lu L, Liu C, Li W, Liu T, Fu W (2015) HER2/neu overexpression predicts poor outcome in early gastric cancer without lymph node metastasis. Clin Res Hepatol Gastroenterol 39(1):121–126. https://doi.org/10.1016/j.clinre.2014.06.019

    Article  PubMed  CAS  Google Scholar 

  3. Grillo F, Fassan M, Sarocchi F, Fiocca R, Mastracci L (2016) HER2 heterogeneity in gastric/gastroesophageal cancers: from benchside to practice. World J Gastroenterol 22(26):5879–5887. https://doi.org/10.3748/wjg.v22.i26.5879

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ieni A, Barresi V, Rigoli L, Caruso RA, Tuccari G (2015) HER2 status in premalignant, early, and advanced neoplastic lesions of the stomach. Dis Markers 2015:234851. https://doi.org/10.1155/2015/234851

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Ieni A, Barresi V, Caltabiano R, Caleo A, Bonetti LR, Lanzafame S, Zeppa P, Caruso RA, Tuccari G (2014) Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis. Int J Mol Sci 15(12):22331–22341. https://doi.org/10.3390/ijms151222331

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

A.I. and G.T.: designed the study and edited the manuscript.

R.C. and M.L.: reviewed the manuscript.

All authors gave final approval for publication.

Corresponding author

Correspondence to Antonio Ieni.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ieni, A., Cardia, R., Lentini, M. et al. Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutic management. Virchows Arch 474, 401–402 (2019). https://doi.org/10.1007/s00428-018-2502-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-018-2502-2

Navigation